Factors Associated With Decision to Withdraw Life-Supporting Treatment in Patients With Severe Traumatic Brain Injury

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, JUNE 17, 2020

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2020.1790?guestAccessKey=09a79100-6528-41bb-91d5-7aac9fde3aad&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061720

 

What The Study Did: Researchers examined what demographic and clinical factors are associated with the decision to withdraw life-supporting treatment in patients with severe traumatic brain injury using data from more than 825 trauma centers in the U.S.

Authors: Theresa Williamson, M.D., of Duke University Medical Center in Durham, North Carolina, is the corresponding author.

 

(doi:10.1001/jamasurg.2020.1790)

Editor’s Note: The article includes conflict of interest disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.